Live birth following serial vitrification of embryos and PGD for fragile X syndrome in a patient with the premutation and decreased ovarian reserve

Journal of Assisted Reproduction and Genetics

Volumn 30, Issue 11, 2013, Pages 1439-1444

  Nayot, Dan ^a   Chung, Jin Tae ^a   Son, Weon Young ^a   Ao, Assangla ^a   Hughes, Mark ^b   Dahan, Michael H ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b Applied Genomics Technology Center of Michigan   (United States)

Author keywords

Array Comparative Genomic Hybridization (aCGH); Diminished Ovarian Reserve (DOR); Embryo vitrification; Fragile X Syndrome (FXS); In vitro maturation (IVM); Preimplantation Genetic Diagnosis (PGD)

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE; CLOMIFENE CITRATE; ESTRADIOL; FOLLITROPIN; PROGESTERONE;

ADULT; ARTICLE; BLASTOCYST; BLIGHTED OVUM; CASE REPORT; COMPARATIVE GENOMIC HYBRIDIZATION; EMBRYO; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FEVER; FRAGILE X SYNDROME; GENETIC SCREENING; GERMINAL VESICLE; GESTATIONAL AGE; HUMAN; IN VITRO OOCYTE MATURATION; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; LUTEAL PHASE; NIDATION; OOCYTE; OOCYTE RETRIEVAL; OVARIAN RESERVE; OVARY INSUFFICIENCY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SPONTANEOUS ABORTION; VITRIFICATION;

ADULT; CRYOPRESERVATION; EMBRYO IMPLANTATION; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FRAGILE X SYNDROME; HUMANS; INFERTILITY, FEMALE; LIVE BIRTH; OVARY; PREGNANCY; PREIMPLANTATION DIAGNOSIS; SPERM INJECTIONS, INTRACYTOPLASMIC; VITRIFICATION;

EID: 84890552264     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-013-0079-x     Document Type: Article

References (24)

1. Aanesen A, Nygren KG, Nylund L. Modified natural cycle IVF and mild IVF: a 10 year Swedish experience. Reprod Biomed Online. 2010;20(1):156-62.
2. Ao A, Jin S, Rao D, Son WY, Chian RC, Tan SL. First successful pregnancy outcome after preimplantation genetic diagnosis for aneuploidy screening in embryos generated from natural-cycle in vitro fertilization combined with an in vitro maturation procedure. Fertil Steril. 2006;85(5):1510-e9-11.
3. Ao A, Zhang XY, Tan SL. First successful pregnancy following PGD for chromosome translocation on embryos generated from in-vitro matured oocytes: a case report. Reprod Biomed Online. 2011;22(4):371-5.
4. Buckett WM, Chian RC, Dean NL, Sylvestre C, Holzer HE, et al. Pregnancy loss in pregnancies conceived after in vitro oocyte maturation, conventional in vitro fertilization, and intracytoplasmic sperm injection. Fertil Steril. 2008;90(3):546-50.
5. Fridén B, Hreinsson J, Hovatta O. Birth of a healthy infant after in vitro oocyte maturation and ICSI in a woman with diminished ovarian response: case report. Hum Reprod. 2005;20(9):2556-8.
6. Gallagher A, Hallahan B. Fragile X-associated disorders: a clinical overview. J Neurol. 2012;259(3):401-13.
7. Gleicher N, Barad DH. The FMR1 gene as regulator of ovarian recruitment and ovarian reserve. Obstet Gynecol Surv. 2010;65(8):523-30.
8. Gleicher N, Kim A, Weghofer A, Barad DH. Differences in ovarian aging patterns between races are associated with ovarian genotypes and sub-genotypes of the FMR1 gene. Reprod Biol Endocrinol. 2012;10:77.
9. Gleicher N, Weghofer A, Barad DH. Defining ovarian reserve to better understand ovarian aging. Reprod Biol Endocrinol. 2011;9:23.
10. Li J, Xu Y, Zhou G, Guo J, Xin N. Natural cycle IVF/IVM may be more desirable for poor responder patients after failure of stimulated cycles. J Assist Reprod Genet. 2011;28(9):791-5.
11. Liu J, Lu G, Qian Y, Mao Y, Ding W. Pregnancies and births achieved from in vitro matured oocytes retrieved from poor responders undergoing stimulation in in vitro fertilization cycles. Fertil Steril. 2003;80(2):447-9.
12. Lukaszuk K, Kunicki M, Liss J, Lukaszuk M, Jakiel G. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization. Eur J Obstet Gynecol Reprod Biol. 2013;168(2):173-7.
13. Nolin SL, Brown WT, Glicksman A, Houck Jr GE, Gargano AD, et al. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet. 2003;72(2):454-64.
14. Requena A, Bronet F, Guillén A, Agudo D, Bou C, et al. The impact of in-vitro maturation of oocytes on aneuploidy rate. Reprod Biomed Online. 2009;18(6):777-83.
15. Schoolcraft WB, Fragouli E, Stevens J, Munne S, Katz-Jaffe MG, et al. Clinical application of comprehensive chromosomal screening at the blastocyst stage. Fertil Steril. 2010;94(5):1700-6.
16. Son WY, Chung JT, Chian RC, Herrero B, Demirtas E, Elizur S, et al. A 38 h interval between hCG priming and oocyte retrieval increases in vivo and in vitro oocyte maturation rate in programmed IVM cycles. Hum Reprod. 2008;23(9):2010-6.
17. Son WY, Chung JT, Dahan M, Reinblatt S, Tan SL, et al. Comparison of fertilization and embryonic development in sibling in-vivo matured oocytes retrieved from different sizes follicles from in vitro maturation cycles. J Assist Reprod Genet. 2011;28(6):539-44.
18. Son WY, Chung JT, Das M, Buckett W, Demirtas E, Holzer H. Fertilization, embryo development, and clinical outcome of immature oocytes obtained from natural cycle in vitro fertilization. J Assist Reprod Genet. 2013;30(1):43-7.
19. Son WY, Chung JT, Gidoni Y, Holzer H, Levin D, et al. Comparison of survival rate of cleavage stage embryos produced from in vitro maturation cycles after slow freezing and after vitrification. Fertil Steril. 2009;92(3):956-8.
20. Son WY, Yoon SH, Lim JH. Effect of gonadotrophin priming on in-vitro maturation of oocytes collected from women at risk of OHSS. Reprod Biomed Online. 2006;13(3):340-8.
21. Van Esch H. The Fragile X premutation: new insights and clinical consequences. Eur J Med Genet. 2006;49(1):1-8.
22. Yakut T, Karkucak M, Sher G, Keskintepe L. Comparison of aneuploidy frequencies between in vitro matured and unstimulated cycles oocytes by metaphase comparative genomic hybridization (mCGH). Mol Biol Rep. 2012;39(5):6187-91.
23. Zhang XY, Ata B, Son WY, Buckett WM, Tan SL, et al. Chromosome abnormality rates in human embryos obtained from in-vitro maturation and IVF treatment cycles. Reprod Biomed Online. 2010;21(4):552-9.
24. Zhang L, Yilmaz A, Chian RC, Son WY, Zhang XY, Kong D, et al. Reliable preimplantation genetic diagnosis in thawed human embryos vitrified at cleavage stages without biopsy. J Assist Reprod Genet. 2011;28(7):597-602.